| __timestamp | Bristol-Myers Squibb Company | Merus N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 944841 |
| Thursday, January 1, 2015 | 16560000000 | 1437692 |
| Friday, January 1, 2016 | 19427000000 | 2859576 |
| Sunday, January 1, 2017 | 20776000000 | 14882309 |
| Monday, January 1, 2018 | 22561000000 | 35973461 |
| Tuesday, January 1, 2019 | 26145000000 | 31133000 |
| Wednesday, January 1, 2020 | 42518000000 | 29943000 |
| Friday, January 1, 2021 | 46385000000 | 49107000 |
| Saturday, January 1, 2022 | 46159000000 | 41586000 |
| Sunday, January 1, 2023 | 45006000000 | 43947000 |
| Monday, January 1, 2024 | 48300000000 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Bristol-Myers Squibb Company has consistently outperformed Merus N.V. in terms of revenue. From 2014 to 2023, Bristol-Myers Squibb's revenue surged by approximately 184%, peaking in 2021 with a staggering $46 billion. In contrast, Merus N.V., a smaller player in the industry, saw its revenue grow from under $1 million in 2014 to nearly $44 million in 2023, marking an impressive growth rate of over 4,500%.
While Bristol-Myers Squibb's revenue dwarfs that of Merus N.V., the latter's rapid growth highlights its potential in the biotech sector. This comparison underscores the diverse strategies and market dynamics at play within the pharmaceutical industry, where both established giants and emerging innovators vie for market share.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: Dr. Reddy's Laboratories Limited and Merus N.V. Performance Compared
Annual Revenue Comparison: Merus N.V. vs HUTCHMED (China) Limited
Merus N.V. vs Novavax, Inc.: Examining Key Revenue Metrics